• Medistim’s third-quarter 2026 operating profit jumped 56% year over year to NOK 63.15 million.
• Revenue climbed 26% year over year to NOK 209.99 million.
• Imaging product revenue rose 58% year over year to NOK 72.66 million.
• The board declared a quarterly dividend of NOK 2.50 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medistim ASA published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.